AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Historical Holders from Q1 2016 to Q3 2025

Symbol
AVNS on NYSE
CUSIP
05350V106
Type / Class
Equity / Common Stock - $0.01 Par Value
Shares outstanding
46.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
44.9M
Holdings value
$520M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
266
Number of buys
129
Number of sells
-119
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.8% $84.9M 6.83M BlackRock, Inc. Mar 31, 2025
T. Rowe Price Investment Management, Inc. 10.2% +25% $54.5M $11.1M 4.71M +25.4% T. Rowe Price Investment Management, Inc. Sep 30, 2025
VANGUARD GROUP INC 7.38% -22.7% $39.6M -$12M 3.43M -23.3% The Vanguard Group Sep 30, 2025
RGM Capital, LLC 6.5% $37.1M 2.99M RGM Capital, LLC Dec 31, 2024
ARMISTICE CAPITAL, LLC 5.39% $28.9M 2.5M Armistice Capital, LLC Sep 30, 2025
DIMENSIONAL FUND ADVISORS LP 5.1% $27.2M 2.35M Dimensional Fund Advisors LP Sep 30, 2025

Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 44.9M $520M -$418K $11.56 266
2025 Q2 44.7M $547M +$14.2M $12.24 279
2025 Q1 43.4M $623M -$6.74M $14.33 273
2024 Q4 43.2M $687M +$2.4M $15.92 249
2024 Q3 42.7M $1.03B +$11.5M $24.03 255
2024 Q2 42.3M $843M -$14.4M $19.92 254
2024 Q1 43.1M $859M -$17.7M $19.91 253
2023 Q4 1.06M $23.9M -$1.54M $22.44 3
2023 Q3 42.7M $864M -$24.4M $20.22 246
2023 Q2 43.3M $1.11B -$10.2M $25.56 262
2023 Q1 43.8M $1.3B +$18.3M $29.74 274
2022 Q4 43.3M $1.17B +$4.21M $27.06 268
2022 Q3 41.2M $897M -$2.88M $21.78 208
2022 Q2 43.3M $1.18B -$12.8M $27.34 221
2022 Q1 43.6M $1.46B +$752K $33.50 247
2021 Q4 42.5M $1.47B -$4.29M $34.67 241
2021 Q3 43.2M $1.35B -$24.2M $31.20 231
2021 Q2 44.4M $1.61B -$404K $36.37 237
2021 Q1 44.1M $1.93B -$43.5M $43.74 256
2020 Q4 44.5M $2.04B -$24.5M $45.88 230
2020 Q3 45.8M $1.52B -$9.07M $33.22 218
2020 Q2 46.2M $1.36B +$22.9M $29.39 223
2020 Q1 45.4M $1.22B -$26M $26.93 210
2019 Q4 45.8M $1.54B +$20.5M $33.70 240
2019 Q3 45M $1.69B -$4.08M $37.46 241
2019 Q2 45.1M $1.97B +$48.1M $43.61 267
2019 Q1 44.9M $1.92B +$47.7M $42.68 287
2018 Q4 43.8M $1.96B -$16.4M $44.79 298
2018 Q3 42.7M $2.92B +$2.85B $68.50 345
2018 Q2 1.04M $59.6M +$59.5M $57.26 33
2018 Q1 332 $15.3K +$599 $46.08 2
2017 Q4 319 $14.7K $0 $46.18 2
2017 Q3 319 $14.4K -$1.26K $45.03 2
2017 Q2 347 $13.6K $0 $39.28 3
2017 Q1 347 $13.2K -$457 $38.08 3
2016 Q4 359 $13.3K -$2.74K $36.98 3
2016 Q3 432 $15K -$1.63K $34.66 2
2016 Q2 479 $15.6K $0 $32.52 2
2016 Q1 611 $19.8K $0 $28.73 3